DailyRounds / Marrow Revenue and Competitors

IND

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • DailyRounds / Marrow's estimated annual revenue is currently $33.6M per year.(i)
  • DailyRounds / Marrow's estimated revenue per employee is $87,500

Employee Data

  • DailyRounds / Marrow has 384 Employees.(i)
  • DailyRounds / Marrow grew their employee count by 7% last year.

DailyRounds / Marrow's People

NameTitleEmail/Phone
1
Strategic HR PartnerReveal Email/Phone
2
Software DeveloperReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.1M1015%N/AN/A
#2
$1.3M264%N/AN/A
#3
$14.1M18326%N/AN/A
#4
$886.2M904310%N/AN/A
#5
$8.7M124N/AN/AN/A
#6
$6.9M99-3%N/AN/A
#7
$11.4M151-13%$9.4MN/A
#8
$169.6M173113%N/AN/A
#9
$7.5M1076%N/AN/A
#10
$169.8M173329%N/AN/A
Add Company

What Is DailyRounds / Marrow?

DailyRounds is the largest academic network of Medical Doctors Built by a team of doctors and coders, DailyRounds now has 300,000+ Doctors. 400 new Doctors join our platform everyday. With clinical case focus we are building a free academic network for Doctors. Marrow is a NEET PG preparation platform peer-reviewed by India?s top medical faculty and NEET PG exam toppers. Used by over 200,000 students, Marrow is now the Gold standard for new pattern NEET PG.

keywords:Healthcare, Pharmaceuticals, Doctors

N/A

Total Funding

384

Number of Employees

$33.6M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

DailyRounds / Marrow News

2016-09-21 - DailyRounds is a social network/medical journal for doctors

DailyRounds, a service for doctors that combines elements of a social network and a medical journal, has landed undisclosed funding led by venture capital giant Accel. Beenos, Powerhouse Ventures and Aksua Holdings are participated in the deal, which follows a $500,000 seed round raised last yea ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$100.8M384N/AN/A
#2
$97.9M38414%N/A
#3
$69.6M3844%N/A
#4
$7.5M3848%N/A
#5
$75M38425%N/A